Viking Therapeutics (VKTX) Invested Capital (2015 - 2018)
Viking Therapeutics (VKTX) posted Invested Capital of $1.9 million for Q1 2018, little changed sequentially from $1.9 million in Q4 2017, and down 1.95% YoY from $2.0 million in Q1 2017.
Viking Therapeutics (VKTX) Invested Capital (2015 - 2018) Analysis & Trends
Viking Therapeutics has reported Invested Capital for 4 years, with the latest figure at $1.9 million in Q1 2018.
- Quarterly Invested Capital fell 1.95% year-over-year to $1.9 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $1.9 million (down 75.24% YoY) and the FY2017 annual result came in at $1.9 million, down 1.95% from the prior year.
- Invested Capital held at $1.9 million in Q1 2018 per VKTX's latest filing, from $1.9 million in the prior quarter.
- Over five years, Invested Capital peaked at $2.5 million in Q4 2015 and troughed at $1.9 million in Q3 2017.
- A 4-year average of $2.0 million and a median of $2.0 million in 2016 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2016 and 2017: Invested Capital fell 21.79% in 2016, then changed 0.0% in 2017.
- Over 4 years, Invested Capital stood at $2.5 million in 2015, then decreased by 21.79% to $2.0 million in 2016, then declined by 1.95% to $1.9 million in 2017, then changed by 0.0% to $1.9 million in 2018.
- According to Business Quant data, Invested Capital over the past three periods registered $1.9 million, $1.9 million, and $1.9 million for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Viking Therapeutics | 3.87 Bn | 3.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1.92 Mn |
| Dec 31, 2017 | 1.92 Mn |
| Sep 30, 2017 | 1.92 Mn |
| Jun 30, 2017 | 1.96 Mn |
| Mar 31, 2017 | 1.96 Mn |
| Dec 31, 2016 | 1.96 Mn |
| Sep 30, 2016 | 1.96 Mn |
| Jun 30, 2016 | 1.96 Mn |
| Dec 31, 2015 | 2.50 Mn |